DNMR Stock Overview
A performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Danimer Scientific, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.66 |
52 Week High | US$3.13 |
52 Week Low | US$0.60 |
Beta | 1.61 |
1 Month Change | -12.55% |
3 Month Change | -57.79% |
1 Year Change | -78.41% |
3 Year Change | -97.13% |
5 Year Change | n/a |
Change since IPO | -93.13% |
Recent News & Updates
News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts
May 21Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 10Recent updates
News Flash: Analysts Just Made A Substantial Upgrade To Their Danimer Scientific, Inc. (NYSE:DNMR) Forecasts
May 21Danimer Scientific, Inc. (NYSE:DNMR) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 10Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher
Apr 25Danimer Scientific Is In Trouble
Nov 17Danimer Scientific: It's Not Time To Buy
Sep 05Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream
Jun 20Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)
May 15Danimer Scientific: Falling Momentum As Cash Burn Climbs
Dec 19What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates
Nov 17Danimer Scientific: Biodegradable Plastics Are Still Important
Sep 30Danimer Scientific stock slides on $100M securities offering
Aug 26These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat
Aug 17Danimer Scientific: Bright Future But Currently A Murky Investment Case
Jun 07Danimer Scientific: An Innovative Bioplastics Player With Huge Upside Potential
Mar 10Danimer Scientific: Growth Opportunities Will Promote Its Stock Price
Dec 24What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates
Nov 25Danimer Scientific: Prepare For Takeoff
Aug 19Shareholder Returns
DNMR | US Chemicals | US Market | |
---|---|---|---|
7D | -4.1% | -0.2% | 1.2% |
1Y | -78.4% | 6.3% | 20.8% |
Return vs Industry: DNMR underperformed the US Chemicals industry which returned 9.2% over the past year.
Return vs Market: DNMR underperformed the US Market which returned 22.5% over the past year.
Price Volatility
DNMR volatility | |
---|---|
DNMR Average Weekly Movement | 13.6% |
Chemicals Industry Average Movement | 4.9% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: DNMR's share price has been volatile over the past 3 months.
Volatility Over Time: DNMR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2004 | 257 | Stephen Croskrey | www.danimerscientific.com |
Danimer Scientific, Inc., a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative under the Nodax brand name for applications in films, straws, cutlery, food containers, and others; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company products are used in various applications, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles.
Danimer Scientific, Inc. Fundamentals Summary
DNMR fundamental statistics | |
---|---|
Market cap | US$77.17m |
Earnings (TTM) | -US$146.10m |
Revenue (TTM) | US$44.98m |
1.7x
P/S Ratio-0.5x
P/E RatioIs DNMR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DNMR income statement (TTM) | |
---|---|
Revenue | US$44.98m |
Cost of Revenue | US$69.16m |
Gross Profit | -US$24.17m |
Other Expenses | US$121.92m |
Earnings | -US$146.10m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -1.25 |
Gross Margin | -53.74% |
Net Profit Margin | -324.79% |
Debt/Equity Ratio | 150.3% |
How did DNMR perform over the long term?
See historical performance and comparison